SUVEN LIFE SCIENCES
Back to Balance Sheet
|
SUVEN LIFE SCIENCES Last 5 Year Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Current Liabilities | - | - | - | - | - |
What is the latest Current Liabilities ratio of SUVEN LIFE SCIENCES ?
| Year | Current Liabilities |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | - |
| Mar2022 | - |
| Mar2021 | - |
How is Current Liabilities of SUVEN LIFE SCIENCES Trending?
| Years | Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 0 | |
| Mar2023 | - | 0 | |
| Mar2022 | - | 0 | |
| Mar2021 | - | - | |
Compare Current Liabilities of peers of SUVEN LIFE SCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN LIFE SCIENCES | ₹6,253.6 Cr | -4.6% | 29.5% | 18.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹427,933.0 Cr | -1.2% | -2.3% | 5.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,833.0 Cr | -1% | -0.9% | -0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,549.0 Cr | -1.3% | 1.4% | 38.1% | Stock Analytics | |
| CIPLA | ₹113,155.0 Cr | -0.1% | 4.8% | -6.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,652.0 Cr | -2.8% | -0.3% | 1.2% | Stock Analytics | |
SUVEN LIFE SCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN LIFE SCIENCES | -4.6% |
29.5% |
18.8% |
| SENSEX | -0.7% |
-3.6% |
-9.1% |
You may also like the below Video Courses